EIC Accelerator

MODERATE Tx General

Strategy Notes

The venture's AI-driven drug resistance prediction aligns well with EIC Accelerator's deep tech focus. The founder's sole-author status and pre-incorporation stage are acceptable, and the non-dilutive funding up to €2.5M matches the sought amount. The EU geography and biopharma network targets are a strong fit.

Key Materials

—

Your Notes

Status & Deadline

Status: HUMAN_REQUIRED
Deadline: rolling
Cycle: rolling
Amount: up to €2.5M
Type: grant
URL: Apply

Update Status

Log Application

AI Pipeline

Research Programme Generate Draft

Status History

2026-07-28 OPEN → HUMAN_REQUIRED · Prepare a concise (≈5 min) pitch video presenting the AI‑driven drug‑resistance prediction platform, record it, and upload it together with the written application via the EU Funding & Tenders Portal.